Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 2004

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver

function tests -- a randomized comparative study with Norplant implants.

AUTHORS

Biswas A; Biswas S; Viegas OA

SOURCE

Contraception. 2004;70:379-382.

ABSTRACT

The study aimed to assess the possible differences in effects of Implanon and Norplant implants on liver function

over 2 years of use. This is a 2-year open randomized study of 80 implant (Implanon and Norplant) acceptors.

Selected parameters of liver function were tested in the serum before implant insertion and at 6, 12 and 24 months

after implant insertion. In both the implant groups, the mean total and unconjugated bilirubin and the gamma-glutaryl

transferase levels were significantly raised during implant use. For none of the subjects, at any sampling period, did

the levels exceed the normal range in our population. There was no significant elevation of any other liver enzymes in

either group. It appears that there may be mild hepatocellular dysfunction associated with the use of both Implanon

and Norplant, which is possibly of no clinical significance to the healthy acceptor. (PubHealth.info Document ID:

CONT1T 531-06)

PubHealth.info NOTE: The author(s) of this article titled, "Effect of etonogestrel subdermal contraceptive implant

(Implanon) on liver function tests -- a randomized comparative study with Norplant implants.", is(are) Biswas A;

Biswas S; Viegas OA. The source of this article is "Contraception. 2004;70:379-382.". This article was published in

2004 in English language(s). (PubHealth.info® Document ID: CONT1T 531-06. All rights reserved with

PubHealth.info) PIN: 531

This article is peer-reviewed.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.